-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
4D Molecular Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2021 to 2023.
- 4D Molecular Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -26.2 %, a 16.8% increase year-over-year.
- 4D Molecular Therapeutics, Inc. annual Return On Assets for 2023 was -31.1 %, a 15.5% increase from 2022.
- 4D Molecular Therapeutics, Inc. annual Return On Assets for 2022 was -36.8 %, a 44.2% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)